The company Neuralink, which specializes in brain-computer communication technologies, their potential integration with computers, and artificial intelligence, has announced the possibility of beginning to implant microchips in humans in 2022. Elon Musk founded Neuralink in 2016. Since then, the company has been dedicated to developing a chip that can be implanted in human brains to stimulate brain activity, as well as recording human implications related to health treatments, such as spinal cord injuries and other neurological disorders. During the entrepreneur\'s participation in the CEO Council Summit organized by The Wall Street Journal, he referred to the company\'s plans for 2022. Next year, the company intends to begin human trials of the chip it presented in 2020; so far, it has only been tested on monkeys. \"Neuralink is working well in monkeys. We\'re conducting many tests and have confirmed that it\'s safe and reliable, and that the device can be safely removed,\" stated the company\'s co-founder, referencing the video released this year showing a monkey playing Pong telepathically. For the company to begin implanting the microchip, only approval from the U.S. Food and Drug Administration (FDA) is needed. According to Elon Musk, the first people to undergo trials will be those who have suffered a spinal cord injury. The aim is to provide them with alternative tools to cope with daily life, such as controlling objects with their minds; and at the same time, the study will explore whether it\'s possible for them to recover motor functions lost in an accident, he explained.